Theralase Technologies Inc. (TLT) — Capital Reinvestment Ratio
Theralase Technologies Inc. (TLT) has a Capital Reinvestment Ratio of 0.05x as of September 2018, meaning it reinvests 0% of its operating cash flow (CA$436.21K) in capital expenditures (CA$19.98K). See net asset quality index of Theralase Technologies Inc. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Theralase Technologies Inc. Capital Reinvestment Ratio (2005–2005)
This chart tracks Theralase Technologies Inc.'s Capital Reinvestment Ratio across 1 annual periods. Check TLT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Theralase Technologies Inc. (2005–2005)
Year-by-year Capital Reinvestment Ratio for Theralase Technologies Inc. from 2005 to 2005. For live market cap and broader valuation context, see how much is Theralase Technologies Inc. worth.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2005 | 1.00x | CA$85.33K | CA$85.30K | — |